Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Nov;66(2):373–383.

Responses of 'mature' human B lymphocyte lines to inducers of maturation and activation.

H Zola, V Griffith, I Hunter, L Koh, J Bradley
PMCID: PMC1542533  PMID: 3493100

Abstract

Four human B cell lines with a mature phenotype (immunoglobulin secretion and expression of membrane markers associated with maturation) were cultured in the presence of phorbol ester (PMA), dimethyl sulphoxide (DMSO) and two conditioned media. PMA and DMSO led to changes in phenotype which suggested the cells were being activated, whilst the conditioned media resulted in increased immunoglobulin secretion, accompanied by phenotypic changes more consistent with maturation towards the plasma cell stage. The four cell lines, which had different origins (EBV-transformed normal B cell, Burkitt's lymphoma, prolymphocytic leukaemia and multiple myeloma) responded differently to the culture stimuli. These differences suggest that the changes associated with transformation affect the way in which these cells respond to agents which stimulate activation and maturation.

Full text

PDF
373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F., Nadler L. M. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun;63(6):1424–1433. [PubMed] [Google Scholar]
  2. Anderson K. C., Bates M. P., Slaughenhoupt B., Schlossman S. F., Nadler L. M. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol. 1984 Jun;132(6):3172–3179. [PubMed] [Google Scholar]
  3. Beckman I. G., Bradley J., Brooks D., Zola H. Delineation of serologically distinct monomorphic determinants of human MHC class II antigens: evidence of heterogeneity in their topographical distribution. Mol Immunol. 1984 Mar;21(3):205–214. doi: 10.1016/0161-5890(84)90075-0. [DOI] [PubMed] [Google Scholar]
  4. Berman J. W., Basch R. S. Amplification of the biotin-avidin immunmofluorescence technique. J Immunol Methods. 1980;36(3-4):335–338. doi: 10.1016/0022-1759(80)90138-6. [DOI] [PubMed] [Google Scholar]
  5. Boyd A. W., Anderson K. C., Freedman A. S., Fisher D. C., Slaughenhoupt B., Schlossman S. F., Nadler L. M. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J Immunol. 1985 Mar;134(3):1516–1523. [PubMed] [Google Scholar]
  6. Braziel R. M., Sussman E., Jaffe E. S., Neckers L. M., Cossman J. Induction of immunoglobulin secretion in follicular non-Hodgkin's lymphomas: role of immunoregulatory T cells. Blood. 1985 Jul;66(1):128–134. [PubMed] [Google Scholar]
  7. Brooks D. A., Beckman I., Bradley J., McNamara P. J., Thomas M. E., Zola H. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes. Clin Exp Immunol. 1980 Feb;39(2):477–485. [PMC free article] [PubMed] [Google Scholar]
  8. Caligaris-Cappio F., Janossy G., Campana D., Chilosi M., Bergui L., Foà R., Delia D., Giubellino M. C., Preda P., Gobbi M. Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res. 1984;8(4):567–578. doi: 10.1016/0145-2126(84)90005-5. [DOI] [PubMed] [Google Scholar]
  9. Capobianchi M. R., Ameglio F., Tosi R., Dolei A. Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: comparison to other interferons. Hum Immunol. 1985 May;13(1):1–11. doi: 10.1016/0198-8859(85)90022-9. [DOI] [PubMed] [Google Scholar]
  10. Chechik B. E., Minowada J. Quantitation of human thymus-leukemia-associated antigen in established hematopoietic cell lines by radioimmunoassay. J Natl Cancer Inst. 1979 Sep;63(3):609–614. doi: 10.1093/jnci/63.3.609. [DOI] [PubMed] [Google Scholar]
  11. Fauci A. S., Lane H. C., Volkman D. J. Activation and regulation of human immune responses: implications in normal and disease states. Ann Intern Med. 1983 Jul;99(1):61–75. doi: 10.7326/0003-4819-99-1-61. [DOI] [PubMed] [Google Scholar]
  12. Haynes B. F. Human T lymphocyte antigens as defined by monoclonal antibodies. Immunol Rev. 1981;57:127–161. doi: 10.1111/j.1600-065x.1981.tb00445.x. [DOI] [PubMed] [Google Scholar]
  13. Herrmann F., Dörken B., Ludwig W. D., Schwarting R. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies. Leuk Res. 1985;9(5):529–536. doi: 10.1016/0145-2126(85)90132-8. [DOI] [PubMed] [Google Scholar]
  14. Johnstone A. P., Millard R. E. Quantitation of immunoglobulin isotypes in chronic lymphocytic leukaemic cells compared with normal adult and neonatal lymphocytes. Int Arch Allergy Appl Immunol. 1985;76(4):313–317. doi: 10.1159/000233713. [DOI] [PubMed] [Google Scholar]
  15. Kehrl J. H., Fauci A. S. Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes. J Exp Med. 1983 May 1;157(5):1692–1697. doi: 10.1084/jem.157.5.1692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morley A. A., Trainor K. J., Seshadri R. S. Cloning of human lymphocytes using limiting dilution. Exp Hematol. 1983 May;11(5):418–424. [PubMed] [Google Scholar]
  17. Muraguchi A., Kishimoto T., Miki Y., Kuritani T., Kaieda T., Yoshizaki K., Yamamura Y. T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J Immunol. 1981 Aug;127(2):412–416. [PubMed] [Google Scholar]
  18. Ralph P., Kishimoto T. Tumor promoter phorbol myristic acetate is a T-cell dependent inducer of immunoglobulin secretion in human lymphocytes. Clin Immunol Immunopathol. 1982 Mar;22(3):340–348. doi: 10.1016/0090-1229(82)90051-4. [DOI] [PubMed] [Google Scholar]
  19. Robèrt K. H., Juliusson G., Biberfeld P. Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytoma. Scand J Immunol. 1983 May;17(5):397–401. doi: 10.1111/j.1365-3083.1983.tb00805.x. [DOI] [PubMed] [Google Scholar]
  20. Smart I. J., Koh L. Y. Competitive inhibition enzyme immunoassays for the measurement of human IgG, IgA and IgM. J Immunol Methods. 1983 Jun 10;60(3):329–339. doi: 10.1016/0022-1759(83)90290-9. [DOI] [PubMed] [Google Scholar]
  21. Teranishi T., Hirano T., Arima N., Onoue K. Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor- (TRF) like factor(s). J Immunol. 1982 Apr;128(4):1903–1908. [PubMed] [Google Scholar]
  22. Wong G. H., Clark-Lewis I., Harris A. W., Schrader J. W. Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol. 1984 Jan;14(1):52–56. doi: 10.1002/eji.1830140110. [DOI] [PubMed] [Google Scholar]
  23. Yoshizaki K., Nakagawa T., Kaieda T., Muraguchi A., Yamamura Y., Kishimoto T. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol. 1982 Mar;128(3):1296–1301. [PubMed] [Google Scholar]
  24. Zola H. Differentiation and maturation of human B lymphocytes: a review. Pathology. 1985 Jul;17(3):365–381. doi: 10.3109/00313028509105488. [DOI] [PubMed] [Google Scholar]
  25. Zola H., McNamara P. J., Moore H. A., Smart I. J., Brooks D. A., Beckman I. G., Bradley J. Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens. Clin Exp Immunol. 1983 Jun;52(3):655–664. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES